Juraj, 357 patient vitamin D sufficiency study: 19% lower mortality [p=0.05] https://c19p.org/juraj
copied to clipboard
COVID-19 pneumonia patients with 25(OH)D levels lower than 12 ng/ml are at increased risk of death
et al., International Journal of Infectious Diseases, doi:10.1016/j.ijid.2022.01.044
Retrospective 357 COVID-19 pneumonia patients in Slovakia, showing higher mortality with vitamin D deficiency (<12ng/mL). All patients received vitamin D supplementation in hospital. In multivariable linear regression, vitamin D levels were independently associated with mortality (p=0.0398).
|
risk of death, 19.0% lower, RR 0.81, p = 0.05, high D levels (≥12ng/mL) 127 of 283 (44.9%), low D levels (<12ng/mL) 41 of 74 (55.4%), NNT 9.5.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Juraj et al., 22 Jan 2022, retrospective, Slovakia, peer-reviewed, 13 authors, study period 1 November, 2020 - 30 April, 2021.
Contact:
smaha1@uniba.sk.
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.